M Peter Marinkovich

Title: M Peter Marinkovich: Innovator in Gene Therapy

Introduction

M Peter Marinkovich is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of recessive dystrophic epidermolysis bullosa. With a total of 9 patents to his name, Marinkovich's work has the potential to transform the lives of those affected by this debilitating condition.

Latest Patents

One of Marinkovich's latest patents focuses on gene therapy for recessive dystrophic epidermolysis bullosa using genetically corrected autologous keratinocytes. The methods provided in this patent detail the cell-based delivery of collagen VII for the treatment of epidermolysis bullosa and corneal erosion. Additionally, the patent discloses a composition and a pharmaceutical formulation that includes a keratinocyte sheet or a corneal cell sheet, which are crucial for effective treatment.

Career Highlights

Throughout his career, Marinkovich has worked with esteemed institutions such as Leland Stanford Junior University and the United States Government as represented by the Department of Veterans Affairs. His innovative research and dedication to advancing medical science have established him as a key figure in his field.

Collaborations

Some of Marinkovich's notable coworkers include Alfred T Lane and Jayakumar Rajadas. Their collaborative efforts have contributed to the advancement of gene therapy techniques and the development of new treatment options.

Conclusion

M Peter Marinkovich's work in gene therapy exemplifies the impact of innovation in medicine. His patents and collaborations highlight the importance of research in improving patient outcomes. Through his contributions, Marinkovich continues to pave the way for advancements in the treatment of genetic disorders.